Expression Atlas results for ENSMUSG00000002985

    Apoe Mus musculus apolipoprotein E
Orthologs APOE (Bos taurus), APOE (Canis familiaris), apoeb (Danio rerio), apoea (Danio rerio), APOE (Equus caballus), APOE (Homo sapiens), APOE (Macaca mulatta), Apoe (Rattus norvegicus), APOE (Sus scrofa), apoe (Xenopus tropicalis)
Gene Ontology beta-amyloid binding, negative regulation of endothelial cell proliferation, response to dietary excess, lipid transporter activity, protein binding, phospholipid binding, extracellular region, extracellular space, nucleus, cytoplasm, late endosome, Golgi apparatus, cytosol, plasma membrane, lipid metabolic process, triglyceride metabolic process, cholesterol catabolic process, lipid transport, cellular calcium ion homeostasis, receptor-mediated endocytosis, response to oxidative stress, G-protein coupled receptor signaling pathway, nitric oxide mediated signal transduction, aging, heparin binding, cholesterol metabolic process, lipid binding, regulation of gene expression, negative regulation of platelet activation, positive regulation of cholesterol esterification, positive regulation of cholesterol efflux, peripheral nervous system axon regeneration, long-chain fatty acid transport, antioxidant activity, protein import, cholesterol transporter activity, cGMP-mediated signaling, negative regulation of blood coagulation, dendrite, positive regulation of cGMP biosynthetic process, extrinsic component of external side of plasma membrane, regulation of Cdc42 protein signal transduction, response to retinoic acid, positive regulation of low-density lipoprotein particle receptor catabolic process, response to insulin, cholesterol efflux, phospholipid efflux, very-low-density lipoprotein particle, low-density lipoprotein particle, intermediate-density lipoprotein particle, high-density lipoprotein particle, very-low-density lipoprotein particle remodeling, low-density lipoprotein particle remodeling, high-density lipoprotein particle remodeling, high-density lipoprotein particle assembly, chylomicron remnant clearance, high-density lipoprotein particle clearance, very-low-density lipoprotein particle clearance, lipoprotein metabolic process, lipoprotein biosynthetic process, lipoprotein catabolic process, vasodilation, chylomicron, cholesterol homeostasis, identical protein binding, protein homodimerization activity, neuronal cell body, negative regulation of MAP kinase activity, negative regulation of neuron apoptotic process, negative regulation of blood vessel endothelial cell migration, reverse cholesterol transport, response to ethanol, negative regulation of cholesterol biosynthetic process, positive regulation of axon extension, hydroxyapatite binding, positive regulation of lipid biosynthetic process, metal chelating activity, protein heterodimerization activity, tau protein binding, oligodendrocyte differentiation, artery morphogenesis, negative regulation of inflammatory response, low-density lipoprotein particle receptor binding, positive regulation of nitric-oxide synthase activity, positive regulation of membrane protein ectodomain proteolysis, negative regulation of lipid biosynthetic process, maintenance of location in cell, lipid homeostasis, fatty acid homeostasis, phosphatidylcholine-sterol O-acyltransferase activator activity, positive regulation of dendritic spine development, negative regulation of dendritic spine development, extracellular vesicular exosome, very-low-density lipoprotein particle receptor binding, cellular response to interleukin-1, cellular response to growth factor stimulus, cellular response to cholesterol, lipoprotein particle binding, cardiovascular system development, blood microparticle, negative regulation of cholesterol efflux, alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering, N-methyl-D-aspartate receptor clustering, regulation of beta-amyloid clearance, regulation of neuron death, negative regulation of neuron death, positive regulation of neuron death, negative regulation of postsynaptic membrane organization, positive regulation of postsynaptic membrane organization, negative regulation of presynaptic membrane organization, positive regulation of presynaptic membrane organization, positive regulation of beta-amyloid formation, negative regulation of beta-amyloid formation, regulation of tau-protein kinase activity, negative regulation of dendritic spine maintenance, positive regulation of dendritic spine maintenance, positive regulation of phospholipid efflux, positive regulation of neurofibrillary tangle assembly, negative regulation of phospholipid efflux, negative regulation of lipid transport across blood brain barrier, positive regulation of lipid transport across blood brain barrier
InterPro Apolipoprotein A1/A4/E (family)
Ensembl Family APOLIPOPROTEIN E APO E, UNKNOWN
Ensembl Gene ENSMUSG00000002985
Entrez 11816
UniProt E9Q327, G3UWN5, G3UWW2, G3UZM8, G3UZT1, P08226, Q3TXU4, Q8C6E4
EMAGE MGI:88057
MGI apolipoprotein E
Gene Biotype protein_coding
Design Element 10560624, 1432466_a_at, 4451254, 4509405, 4549499, 4781299, 4852658, 4949843, 4963848, 5111537, 5148350, 5207284, 5290520, 5293248, 5294456, 5358085, 5554133, 5595984, 95356_at, A_51_P171999, Msa.18117.0_f_at, Msa.23293.0_f_at, Msa.4.0_f_at, d00466_f_at
    Baseline Expression Results in tissues
c Expression Level cut-off: 0.5
    Differential Expression 38 results
Showing 38 results cutoffs: adjusted p-value 0.05    log2-fold change 1.0